Johns Hopkins Medicine | oneAMYLOIDOSISvoice
Academic & Health Care Centers

Johns Hopkins Medicine

1800 Orleans St.
Baltimore, Maryland, United States
Phone   Web  

The Johns Hopkins School of Medicine educates medical students, graduate students and postdoctoral fellows to practice patient-centered medicine, to study the prevention and treatment of disease, and to excel in health care delivery and in the basic sciences.

Headquartered in Baltimore, Maryland, Johns Hopkins Medicine unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. Johns Hopkins Medicine has six academic and community hospitals, four suburban health care and surgery centers, over 40 patient care locations, a home care group and an international division, and it offers an array of health care services. 

Johns Hopkins neurologist Michael Polydefkis is one of the few neurologists in the United States who specialize in treating hATTR amyloidosis. Johns Hopkins research into the rare disease leads to approval of the first drug that can halt its progression.

Its mission is to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care.


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.